De novo HBB frameshift mutation in a patient with dominant β‐thalassemia major

Xiaoman Zhou(Southern Medical University), Lu Yang(Weifang Medical University), Qianqian Zhang(Southern Medical University), Li Zhang(Wenzhou Medical University), Ming Qi(University of Cape Town), Bo Shen(Jiangsu Cancer Hospital), Tongtong Chen(Ocean University of China), Juping Du(Wenzhou Medical University), Xiangmin Xu(Southern Medical University), Hongbo Chi(St. Jude Children's Research Hospital)
International Journal of Laboratory Hematology
July 29, 2021
10.1111/ijlh.13669
Cited by 2

Related Papers

HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996
Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis
|Nature Immunology|2016|487
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
|Nature Genetics|2013|476
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
|Nature|2019|445